Gliadel Costs Reduced By 90% At Cedars-Sinai Medical Center
Executive Summary
Cedars-Sinai-Medical Center has reduced its FY 2000 spending on Aventis' Gliadel wafer by more than half after communicating with neurosurgeons about inadequate reimbursement and lack of significant clinical benefit.